Cost-Utility Analysis of Treatment with Olanzapine Compared with Other Antipsychotic Treatments in Patients with Schizophrenia in the Pan-European SOHO Study

被引:0
作者
Martin Knapp
Frank Windmeijer
Jacqueline Brown
Stathis Kontodimas
Spyridon Tzivelekis
Josep Maria Haro
Mark Ratcliffe
Jihyung Hong
Diego Novick
机构
[1] Institute of Psychiatry,Centre for the Economics of Mental Health
[2] London School of Economics,Department of Economics
[3] University of Bristol,European Health Outcomes Research
[4] Eli Lilly and Company,Sant Joan de Deu
[5] Fundació Sant Joan de Déu,SSM
[6] Sant Boi de Llobregat,undefined
来源
PharmacoEconomics | 2008年 / 26卷
关键词
Clozapine; Risperidone; Olanzapine; Quetiapine; Antipsychotic Medication;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:341 / 358
页数:17
相关论文
共 113 条
[1]  
Davies LM(2007)Cost-effectiveness of first-v second-generation antipsychotic drugs: results from a randomised controlled trial in schizophrenia responding poorly to previous therapy Br J Psychiatry 191 14-22
[2]  
Lewis S(2003)The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment Acta Psychiatr Scand 107 222-232
[3]  
Jones PB(2004)Practice guidelines for the treatment of patients with schizophrenia Am J Psychiatry 161 1-56
[4]  
Haro JM(1999)The expert consensus guideline series: treatment of schizophrenia 1999 J Clin Psychiatry 60 1-82
[5]  
Edgell ET(1998)Translating research into practice: the schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations Schizophr Bull 24 1-10
[6]  
Jones PB(1999)What observational studies can offer decision makers Horm Res 51 44-49
[7]  
Lehman AF(1999)Methods in health services research: interpreting the evidence. Choosing between randomised and non-randomised studies BMJ 319 312-315
[8]  
Steinwachs DM(2005)Effectiveness of anti-psychotic treatment for schizophrenia: 6-month results of the Pan-European Schizophrenia Outpatient Health Outcomes (SOHO) study Acta Psychiatr Scand 111 220-231
[9]  
Black N(1996)EuroQol: the current state of play Health Policy 37 53-72
[10]  
McKee M(2002)Antipsychotic prescribing practices in Connecticut’s public mental health system: rates of changing medications and prescribing styles Schizophr Bull 28 17-29